June 13, 2008 - MEDRAD signed a distribution and co-marketing partnership agreement with PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions, enabling healthcare providers to inject Fluorodeoxyglucose (FDG) for positron emission tomography/computed tomography (PET/CT) imaging procedures in a new way.
MEDRAD’s PET infusion system, Intego, is designed to automatically extract a patient dose from a multidose vial and deliver it directly to the patient. The system is mobile and includes dosimetry, shielding and a touchscreen interface.